Adam Maeder
Stock Analyst at Piper Sandler
(3.69)
# 731
Out of 5,097 analysts
101
Total ratings
52.94%
Success rate
7.58%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Overweight | $135 → $165 | $94.74 | +74.16% | 17 | Dec 8, 2025 | |
| NYXH Nyxoah | Reiterates: Overweight | $12 → $9 | $4.59 | +96.08% | 9 | Nov 14, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4 → $5 | $8.42 | -40.62% | 2 | Nov 7, 2025 | |
| TCMD Tactile Systems Technology | Reiterates: Neutral | $14 → $20 | $29.28 | -31.69% | 4 | Nov 4, 2025 | |
| EW Edwards Lifesciences | Reiterates: Overweight | $90 → $95 | $85.88 | +10.62% | 17 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Overweight | $595 → $610 | $576.83 | +5.75% | 21 | Oct 22, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $8.5 → $7 | $2.07 | +238.16% | 8 | Aug 13, 2025 | |
| RMD ResMed | Maintains: Neutral | $248 → $270 | $244.13 | +10.60% | 4 | Aug 1, 2025 | |
| RXST RxSight | Maintains: Neutral | $18 → $10 | $11.12 | -10.07% | 2 | Jul 9, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.09 | +91.39% | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $133 → $145 | $124.80 | +16.19% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $22.53 | -6.79% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $1.44 | +455.56% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.45 | +104.08% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $0.14 | +12,522.72% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $63.04 | +57.04% | 3 | May 5, 2022 |
Inspire Medical Systems
Dec 8, 2025
Maintains: Overweight
Price Target: $135 → $165
Current: $94.74
Upside: +74.16%
Nyxoah
Nov 14, 2025
Reiterates: Overweight
Price Target: $12 → $9
Current: $4.59
Upside: +96.08%
Sight Sciences
Nov 7, 2025
Maintains: Neutral
Price Target: $4 → $5
Current: $8.42
Upside: -40.62%
Tactile Systems Technology
Nov 4, 2025
Reiterates: Neutral
Price Target: $14 → $20
Current: $29.28
Upside: -31.69%
Edwards Lifesciences
Oct 31, 2025
Reiterates: Overweight
Price Target: $90 → $95
Current: $85.88
Upside: +10.62%
Intuitive Surgical
Oct 22, 2025
Reiterates: Overweight
Price Target: $595 → $610
Current: $576.83
Upside: +5.75%
Vicarious Surgical
Aug 13, 2025
Maintains: Neutral
Price Target: $8.5 → $7
Current: $2.07
Upside: +238.16%
ResMed
Aug 1, 2025
Maintains: Neutral
Price Target: $248 → $270
Current: $244.13
Upside: +10.60%
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $11.12
Upside: -10.07%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.09
Upside: +91.39%
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $124.80
Upside: +16.19%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $22.53
Upside: -6.79%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $1.44
Upside: +455.56%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.45
Upside: +104.08%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $0.14
Upside: +12,522.72%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $63.04
Upside: +57.04%